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The effect of protein concentration on solution viscosity in a commercially available biopharmaceutical formulation of 
recombinant albumin (rAlbumin) was studied. The level of protein aggregation with concentration and its impact on 
solution viscosity was investigated. Theoretical models predicting viscosity with concentration were applied to these data, 
and a model that accounts for multiple protein species in solution provided the best fit. The results highlight the need to 
account for heterogeneity in the level of aggregation when addressing the increase of viscosity observed at high 
concentration of protein solutions, a significant issue for the manufacture and use of protein-based therapeutics. 
Introduction 
The viscosity of protein formulations is an important issue for 
the biopharmaceutical industry due to its practical implications 
in medicine manufacture and administration.1 
Biopharmaceutical liquid formulations are frequently created 
with high protein concentration, due to the need for high mass 
delivery to overcome low potency; low volumes are also 
desirable to allow patient self-administration in cost effective 
devices.1,2 However, when biomacromolecules reach high 
solution concentrations, problems such as high viscosity and 
poor flow properties, as well as stability issues, can occur. 
 Theories from colloidal science have been used to model 
the observed increases in solution viscosities with increased 
macromolecular content.3–5 A number of these are based on 
approximations to hard spherical repulsive particles, and have 
been applied with some success.6,7 However, there are more 
molecular properties, such as shape8, charge distribution9,10 or 
kinetics of association11–13, which need to be considered for 
more accurate predictions of protein solution viscosity. 
Moreover, such properties depend on factors including pH, 
temperature, ionic strength and the presence of additives in 
solution, and therefore these and their impact on the 
formation of higher order oligomeric biomolecular species 
and/or aggregates need also to be considered. 
 The effect of protein concentration on solution viscosity 
has been discussed previously.10,14–19 At dilute concentrations, 
protein solution viscosity has been studied using models that 
account for the hydrodynamic behaviour of proteins in a 
fluid.15 Other theories that account for inter-protein 
interaction potential and excluded volume have been applied 
with relative success in predicting the increase of viscosity with 
protein concentration.4,7 In general, all these models assume 
that (globular) proteins are hard spherical or quasispherical 
macromolecules and, to some extent, are able to explain the 
increase of viscosity with concentration and allow a 
comparison with the behaviour of colloidal dispersions. So far, 
however, there has not been a theoretical model that is 
capable of predicting the viscosity of protein solutions in a 
range from dilute to highly concentrated (>200 mg/mL).  
 Intrinsic viscosity ([η]) is a hydrodynamic parameter that is 
related to the conformation and size of a molecule in dilute 
solution and represents the effective molecular volume at 
these conditions20. It is defined in terms of concentration (c, in 
mg/mL) by the following equation: 
  	 lim	→ 		  (1) 
where η is the solution viscosity and ηo is the viscosity of the 
solvent. One of the hard (quasi)-spherical models relating 
protein viscosity and concentration, is the modified Mooney 
equation21 as per Ross-Minton's approach18 , defined by: 
  	   
	 	  (2) 
where relative viscosity (η/ηo) is an exponential function of 
concentration (c), [η], a crowding effect factor (κ) and Simha's 
shape factor (ν).15 As the crowding effect is a consequence of 
the excluded volume when the protein concentration 
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increases, the model predicts solution viscosity accounting for 
the protein's shape and its excluded volume.  
 From colloidal rheology, the Krieger-Dougherty model (eq. 
3),3   
    1 −  
 	 (3) 
was originally applied to describe infinite dilutions of hard 
spherical particles. In the case of random close packing of 
spheres at low deformations4,22, the intrinsic viscosity ([η]) in 
equation 3 is fixed to 2.5 and is dimensionless, since it is 
defined as a function of volume fraction (!), with a maximum 
packing fraction (!max) of 0.64. Still assuming the spherical 
shape, this maximum packing fraction has been discussed to 
be around 0.71, when the particles are exposed to higher 
shear rates.4 
 The Russel-Saville-Schowalter revision of Batchelor's 
equation4 (eq. 4), is a model which predicts the increase of 
viscosity of hard spherical particles, while taking into account 
interparticle interactions based on the effective distance 
between particles.  
    1 + 2.5! + &!' +((!*) (4) 
where the coefficient s of the quadratic term is defined by, 
&  2.5 + *, -.//0 1  (5) 
and is dependent on the effective interparticle distance, deff, 
and the radius of particle, a. The factor deff is dependent on 
both the hydrodynamic contributions of the particle as well as 
the interaction potential, relevant to the dispersion conditions. 
Batchelor showed that for a concentrated dispersion of hard 
spherical repulsive particles, the value of s is equal to 6.2, 
where deff = 2a. 
4 
 The models described above assume that any change in 
composition of protein species in solution is negligible. 
Parameters in these models typically account for only one 
species of a specific shape and size. Some authors have 
addressed the problem for binary mixtures of different sized 
particles, to predict the impact of this on the solution 
viscosity.5,23–25. In recent reports, binary blends of proteins 
have been studied by controlling the content of each protein in 
solution and understanding the effect of this on the overall 
solution viscosity.14,26 
 Galush et al.26 presented a study on the viscosity of mixed 
protein solutions, using mixtures of different monoclonal 
antibodies (mAbs) and of one mAb with BSA. Their conclusions 
derived from measuring the viscosity of both the individual 
protein solutions and blends. They proposed that the viscosity 
of protein blends could be predicted by an additive function of 
the viscosity of each individual protein multiplied by its 
respective known weight fraction (eq. 6).  
ln 	(3454 , 7')  (1 − 7') ln (3454) + 7' ln '(3454) (6) 
where η1 and η2 are the viscosities of pure protein 1 and 2, 
respectively, f1 and f2 are the weight fractions corresponding 
to the protein 1 and 2 present in the blend and wtot is the total 
weight/volume concentration of the protein mixture. 
 Minton14 has contributed with the generalisation of 
equation 2 and equation 3 and application to predicting the 
viscosity of globular protein solutions containing only one 
protein, but with relatively well-known fractions of its 
monomeric and higher order associative species. The 
generalised models of Ross-Minton (eq. 7) and Krieger-
Dougherty (eq. 8) models, as proposed by Minton, are as 
follows: 

  89 :;	<==;==;∗ ? (7) 

  1 − <==<∗ 
;<∗
 (8) 
 Note that the Krieger-Dougherty equation has been 
modified to allow the use of weight/volume concentrations 
(wtot, in [mg/mL]), rather than volume fractions. Both 
equations 7 and 8 are now represented as functions of wtot, 
[η]w and w*. The parameter [η]w is weight-averaged intrinsic 
viscosity (in [mg/mL]), described in equation 9. The parameter 
w* represents an estimated protein concentration above 
which the solution cannot flow, referred to as jamming 
concentration.14,22  
<  ∑<AA<==  (9) 
 Here a recombinant human albumin (rAlbumin) solution 
formulated in a buffer containing salt and a surfactant was 
studied. The rAlbumin studied is expressed in Saccharomyces 
cerevisiae and has an identical amino acid sequence to human 
serum albumin (HSA).27 HSA is the most abundant protein in 
the blood at a concentration of ~40 mg/mL. It is the major 
transport protein for unesterified fatty acids, having the 
capacity to bind numerous metabolites, active pharmaceutical 
ingredients as well as other organic molecules.28 
 Our study investigated the rheological characteristics of 
HSA samples with concentrations ranging from 0.1 mg/mL to 
approximately 500 mg/mL, using steady shear rheology with a 
torsional rheometer. A detailed biophysical characterisation of 
these samples was performed to account for the level of 
aggregation, size and shape of protein species, within higher 
concentrations of rAlbumin, to probe relationships between 
aggregation and solution viscosity. The ultimate goal was to 
predict the viscosity of highly concentrated globular protein 
solutions, using the abovementioned models to enhance the 
efficacy of formulated biopharmaceuticals. 
 
Materials and Methods 
Materials 
Recombinant human albumin (rAlbumin) was donated by 
Novozymes Biopharma UK Ltd. (Nottingham, UK) in the form 
of Recombumin® Prime (batches: 1104 and 1101). The product 
is a liquid formulation of concentration 200 mg/mL, stored at 
2-8 °C. All other reagents were obtained from Sigma-Aldrich, 
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UK and were of analytical grade. The formulation buffer of 
Recombumin® Prime is composed of NaCl (145 mM), 
polysorbate-80 (15 mg/L) and sodium octanoate (32 mM) in 
ultrapure water (pH = 7.0 ± 0.3 at room temperature). Another 
buffer was prepared containing only NaCl (145 mM) in 
ultrapure water (pH = 7.0 ± 0.3).  
 Centrifugal concentrators (Vivaspin 20 – 5 kDa molecular 
weight cut-off with polyethersulfone membrane; Sartorius 
Stedim, Ltd., UK) were used to concentrate rAlbumin samples 
to higher concentrations than the starting material (200 
mg/mL). The procedure recommended by the manufacturer 
was followed, using a fixed 45º rotor centrifuge (Hermle Z400, 
Labortechnik GmbH, Germany). After centrifugation, samples 
were collected, mixed and checked for their concentration 
using UV-Visible spectroscopy. All samples and the respective 
buffers were stored at 2-8 ºC. 
 
Methods 
Quantification of protein concentration by UV-Visible 
spectroscopy 
An Agilent 8453 UV-Vis spectrophotometer (model G1103, 
Agilent Technologies, Germany) was used to quantify protein 
concentration via absorbance at 280 nm. A quartz cuvette with 
1 cm path length (Hellma, Germany) was used for all 
measurements.  
 For all protein solutions at concentrations higher than 50 
mg/mL, a double dilution scheme was followed to allow a 
measurement of sample diluted to 0.5 mg/mL. Each second 
dilution was produced in triplicate so that the absorbance 
measurement (and posterior concentration calculation) was 
reported as an average of 3 measurements.  
 For the determination of concentration of rAlbumin 
solutions, the percent extinction coefficient at 280 nm (B	%		D) 
used was 5.8.29 
Rheology 
The rheometers used were Anton-Paar (Graz, Austria) MCR 
models 301 and 501. Cone-and-plate geometries used 
throughout this study were stainless steel CP50-1 (diameter = 
50 mm; cone angle = 1° and CP40-0.3 (diameter = 40 mm; cone 
angle = 0.3°). To prevent evaporation of sample and to 
maintain a constant temperature of 20 °C ± 0.1 °C throughout 
the measurements, an evaporation blocking system equipped 
with a peltier unit was used. Prior to measurements, all 
samples were allowed to equilibrate to room temperature (~ 
23 °C) for at least 40 minutes. 
 Rotational tests (flow curves and viscosity curves) were 
performed by controlling the shear rate typically from 0.01 to 
1000 s-1, and measuring torque, shear viscosity and shear 
stress. To increase data validity and sensitivity of the method, 
each shear rate step had a 60 second duration time during 
which the instrument was averaging over the collected data. 
Two shear-rate sweeps (ramping down and up) were 
performed per sample, without waiting time between sweeps. 
The tests were always started after a 10 minute waiting time 
after loading the sample.  
Micro-viscometer/rheometer on-a-chip (mVROC) 
The mVROC, by Rheosense, Inc. (San Ramon, California, USA) 
was used for measurement of air-water interface-free bulk 
viscosity at high shear rates. The mVROC is a microfluidics slit 
rheometer where the microfluidics chip is composed of a 
microchannel (rectangular slit) made of borosilicate glass 
mounted on a gold-coated silicon base. Viscosity is measured 
as a function of pressure drop as the fluid flows in the 
microchannel (width = 3.02 mm; depth depends on the chip 
used). In a typical experiment, the flow rate, Q, is varied using 
a syringe pump and Hamilton gastight glass syringes (Reno, 
Nevada, USA). The mVROC device outputs the pressure drop 
as a function of flow rate, which is used to calculate the 
nominal or apparent viscosity via (E	F )  	 G</EF< .30 The true 
shear rate and true shear viscosities are then calculated, 
respectively, using the Weissenberg-Rabinowitsch-Mooney 
equation.30,31 
 Samples analysed were rAlbumin solutions at 200 and 500 
mg/mL. For these measurements, the A05 and D05 chips were 
used and the temperature was kept constant at 20 °C ± 0.1 °C 
using a water circulation system (ThermoCube, SS cooling 
systems, USA). 
 
High performance size exclusion chromatography (HPSEC) 
Determination of level of protein aggregation  
rAlbumin samples were analysed for their level of aggregation 
on HPSEC. The high performance liquid chromatography 
(HPLC) system used was from Agilent Technologies 1200 series 
(Germany) with the following components: degasser, binary 
pump with a 100 μL injection loop, an autosampler, 
thermostatted sample tray (at 5 °C), a thermostatted (at room 
temperature) column holder and a UV detector. The software 
used for this system was Chemstation for liquid 
chromatography systems, by Agilent Technologies. A Tosoh 
Biosciences, LLC (USA), model TSK gel G3000SWxl column was 
used (7.8 mm (ID) x 30 cm (L)), composed of silica gel particles 
with mean particle size of 5 μm and pore size of 250 Å. A guard 
column (silica particles of 7 μm, 6 mm (ID) x 4 cm (L)) was also 
used with the analytical column. 
 The mobile phase was an aqueous buffer of 0.1 M sodium 
sulfate (Na2SO4) and 0.1 M dibasic sodium phosphate 
anhydrous (Na2HPO4), titrated to pH 6.8 with 6N HCl. This 
buffer was filtered with 0.22 μm pore size vacuum-driven filter 
units (PES membrane, EMD Millipore, USA). 
 All protein samples were diluted to 10 mg/mL, and 
injection volume was 25 μL. Run time was 20 minutes at a flow 
rate of 1 mL/min. Each sample was injected three times. 
Formulation buffers respective to the protein samples were 
also injected as blanks. 
 Bio-Rad gel filtration protein standards (Bio-rad 
Laboratories, Inc., USA) were used for this method’s system 
suitability test. These were prepared according to the 
manufacturer's instructions and 25 μL were injected once at 
the beginning and end of 20 sample injections. 
 All samples, buffers and Bio-Rad protein standards were 
filtered through 0.45 μm centrifugal filters (Ultrafree-MC 
PVDF, EMD Millipore, USA). The obtained chromatograms 
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followed integration and peak symmetry and resolution were 
calculated via the method analysis used on the software. 
  
Analysis with multiple detectors for determination of molecular 
weight and intrinsic viscosity of rAlbumin solutions 
To calculate bulk molecular weight and intrinsic viscosity, the 
chromatography system used was a Polymer Labs GPC 50 Plus 
(Agilent Technologies, USA) gel permeation unit that 
comprised an autosampler, a fixed volume injection loop (20 
μL), thermostatted column holder, and the following 
detectors: a 90º light scattering detector, a refractive index 
detector, and a differential pressure viscometer. Calibration of 
the system was made with polyethylene oxide (Polymer Labs, 
UK) solutions in phosphate buffer saline (Lonza, Inc.). 
 The method details chosen for these experiments were 
similar to the previous section with exception that samples 
were diluted to 15 mg/mL, thus injecting 300 μg of total 
protein. System suitability was still performed with Bio-Rad 
protein standards and the same buffer was used as mobile 
phase. Each rAlbumin sample was injected three times, with 
buffers injected at least once. dn/dc used for protein analysis 
was 0.185 mL/g.32 
 
Dynamic light scattering (DLS) 
Sizing measurements were performed using the Zetasizer 
NanoZS dynamic light scattering instrument (Malvern 
Instruments, UK). Samples were illuminated by a 633 nm laser 
and light scattering was detected at 173° by an avalanche 
photodiode. DLS results were obtained and analysed using the 
Zetasizer software version 7.01. Protein samples were 
measured at 1 mg/mL diluted in sample buffer, to reduce non-
linearity effects on measurements by increased viscosity of 
solvent with higher concentrations. 
 Measurement settings for rAlbumin size readings were at a 
constant temperature of 20 °C, performing 15 runs of 10 
seconds each. An equilibration time of at least 5 minutes was 
set before the measurement started. Size measurements were 
made in triplicate with fresh aliquots for each reading. 
Results 
The rheology of formulated recombinant human albumin 
solutions 
The data in Fig. 1A and 1B show that rAlbumin solutions 
displayed constant shear viscosities for the increasing shear 
rates applied (0.01 to 1000 s-1). Fig. 1C shows a linear increase 
of shear stress with the increasing applied shear rates. For the 
higher concentration materials (400 - 500 mg/mL) the shear 
viscosities were from ~1 s-1 onwards, while showing slight non-
linear increase of viscosities when <1 s-1. However, in general, 
throughout the range of concentrations of rAlbumin presented 
and the applied shear rates, it was considered that these 
solutions exhibited a Newtonian-like behaviour. Each sample 
was measured using two consecutive shear rate sweeps, 
ramping down and up (Fig. 1A and 1B). Hysteresis effects were 
not observed, in agreement with the literature, which suggests 
that the protein molecules diffuse rapidly in the fluid once 
shear is stopped.7,33,34 
 For comparison between the concentration of samples and 
the obtained shear viscosities, the viscosity values at 1000 s-1 
were taken from three separate readings per sample and are 
reported in Fig. 2 as an average with the respective standard 
deviation. The viscosity values reported here are those at high 
shear viscosity (η∞), since the viscosities of these samples were 
overall shear-rate independent.7 In Fig. 2 the average viscosity 
values are reported against the average actual concentrations 
measured for each sample. It was noted that as the targeted 
protein concentrations were increasingly higher, it was more 
difficult to achieve such targets (e.g. ≥ 300 mg/mL; see Table 
SI-1 from ESI). For clarity within this manuscript therefore, 
sample concentrations are referred to as the corresponding 
target concentration. 
 From Fig. 2A, the viscosity values were similar for lower 
protein concentrations. An increase of viscosity with increasing 
concentration was seen, in agreement to what has been 
reported throughout the literature with regards to serum 
albumin solutions.7,10,15 Most importantly, the exponential 
trend observed from the data in Fig. 2A is also reported for 
other globular proteins, such as immunoglobulins.11–13,35 
Characterisation of protein species present in recombinant human 
albumin solutions 
Our aim was to correlate the observed increase in viscosities 
with the level of aggregation present in the increasing 
concentrations of rAlbumin samples. Therefore, the 
identification, relative quantification and size characterisation 
of the monomeric and oligomeric species present in solution 
was performed using HPSEC, DLS and microfluidic SDS-PAGE 
(shown in the ESI).  
 
High-performance size exclusion chromatography (HPSEC) 
HPSEC retention times for the protein species typically present 
were ~7.9, 8.7 and 9.8 minutes, corresponding to trimer, dimer 
and monomers, respectively (see Fig. SI-1 from ESI). This 
method of analysis produced good resolution between the 
different identified species and these were comparable to 
literature values using a similar setup.36 No higher molecular 
weight species other than dimers and trimers were found in 
any of the solutions analysed. This reflected the high purity of 
the recombinant albumin material due to its manufacturing 
process generating only a small percentage of trimers and 
dimers27, with the monomer showing the highest relative 
percentage with a peak area of > 90 %. Samples from 50 to 200 
mg/mL had similar peak areas for all protein species. Only 
when concentrations reached approximately 250 mg/mL and 
over, a trend could be detected on the increase of dimers and 
trimers with a corresponding decrease of monomer (Fig. 2B).  
 Size exclusion chromatography required sample dilution 
for analysis when concentrations were > 10 mg/mL. Dilution is 
a limitation of this method since it can influence the material's 
content in relative percentage of each species, as it can be a 
factor for some aggregates to disassociate, and therefore be 
considered reversible.37,38 It was important to understand if 
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this was the case with rAlbumin solutions. By comparing 
injections of proteins at 50 mg/mL and 10 mg/mL 
concentrations, their respective peak areas were different by 
factors of < 1 % (see Fig. SI-2 from ESI). Such low differences 
indicated that dissociation upon dilution of trimers and dimers 
into monomers was negligible. Moreover, this is in agreement 
with the irreversibility observed of associated dimer and 
trimer species reported in prior literature.39 
 Triple-detection HPSEC was used to experimentally 
determine the intrinsic viscosity and molecular weight (MW) 
for each of the protein species present in rAlbumin samples: 
monomer, dimer and trimer. This determination allowed for 
subsequent analysis discussed ahead in this study. 
 The results were relative to the two peaks detected 
corresponding to monomer and dimer, since the differential 
pressure viscometer could not detect the low percentage of 
trimers present in solution (see Fig. SI-2 from ESI). Analysis of 
peak areas per sample showed a trend of increasing rAlbumin 
dimers, similar to what was observed previously for 
conventional HPSEC (Table 1). 
 
Dynamic light scattering 
The hydrodynamic size analysis of rAlbumin solutions by 
dynamic light scattering (DLS) was performed for the entire 
range of solutions after dilution to 1 mg/mL. All solutions were 
analysed without prior filtration to assess if aggregates were 
present within the detection limit of DLS (up to 1 μm of 
hydrodynamic diameter). In all cases, the samples did not 
show presence of aggregates. For all the analysed samples, the 
measured average hydrodynamic radii from the size 
distributions by intensity ranged between 3.8 - 4.5 nm 
corresponding to values reported in literature40 for a 
recombinant human albumin solution (Fig. 3). The 
hydrodynamic size distribution by volume resulted in one 
peak, with its mean peak value skewed towards lower sizes, 
closer to the monomer size. 
 
Surface tension effects on rheology measurements – control 
experiments 
To ensure that the rheological measurements were taken as 
accurately as possible and were free of artefacts related to the 
method and the technical specifications of the rheometer, 
additional experiments were carried out.  
 The influence of surface tension at the air-water interface 
of protein solutions in surfactant-free buffers has been shown 
to present apparent high-viscosities at low shear rates. The use 
of a conventional rheometer with cone-and-plate geometry 
has been suggested as not being the most appropriate 
instrumentation for these types of samples as it is not an air-
water interface-free technique.7 Therefore, a rAlbumin 
solution at 200 mg/mL (from the original formulation) was 
analysed with the micro viscometer/rheometer-on-a-chip 
(mVROC) method, which provides rheometry measurements 
free of air-water interface. When superimposing the cone-and-
plate (CP) rheometer data with mVROC data, the sample at 
200 mg/mL showed no difference in its viscosity values. As an 
example, at shear rate ≈ 1000 s-1, the average viscosities 
measured with each instrument were η(CP) ≈ 3.5 mPa.s and 
η(mVROC) ≈  3.4 mPa.s (Fig. 4). This clearly showed that the 
rheometer data were most likely free of air-water interfacial 
artefacts. 
 In further experiments, samples were prepared by diluting 
in an aqueous surfactant-free solution of NaCl 145 mM. 
rAlbumin solutions at 5, 10, 50 and 100 mg/mL were measured 
on the rheometer and their level of aggregation was assessed 
by HPSEC and DLS. HPSEC and DLS data were similar to those 
of formulated rAlbumin. However, while samples at 5, 10 and 
50 mg/mL in NaCl 145 mM showed an increase of viscosities 
towards low shear rates; only the sample at 100 mg/mL of 
rAlbumin in NaCl 145 mM presented constant viscosities 
throughout a similar shear rate range (Fig. 5). Samples at 5 and 
10 mg/mL showed a slightly increased high shear viscosity (η∞ 
at EF 	= 1000 s-1), when compared to the data collected from 
formulated samples. 
 Additionally, a test was done to assess if the method of 
concentrating the protein solution would also concentrate the 
surfactant (see SI-7). The original sample at 200 mg/mL and 
the concentrated sample to match 200 mg/mL both presented 
matching viscosity profiles and values. Therefore, to address 
the analysis made in this work, the simplest case was 
considered, where the surfactant would have diffused through 
the concentrator’s membrane during centrifugation for all 
concentrated samples (> 200 mg/mL). 
 
Effect of high protein concentration on solution viscosity 
 The intrinsic viscosity of human serum albumin has been 
reported to be of 4.73×10-3 ± 1.2×10-4 mL/mg, for similar 
solution conditions to these presented here (temperature at 
20 ºC, pH 7.0).8 Values of intrinsic viscosity for bovine serum 
albumin, have been reported to be 3.7×10-3 mL/mg15 or similar 
values.20,41 Although the albumin here used is fatty-acid 
bound, it is expected that the presence of fatty acid in serum 
albumin does not influence the value of intrinsic viscosity.42 
Intrinsic viscosity values in literature for HSA8 and for bovine 
serum albumin (BSA)15 were used to fit the rheometry data 
(Fig. 6) using Ross-Minton’s hard (quasi)-spherical equations 
relating protein viscosity and concentration (eq. 2).  
 Our rheology data was fitted to equation 2, with the 
intrinsic viscosity ([η]) constrained and the κ/ν factor freely 
floating (Fig. 6 – blue and orange line). The computed values 
for κ/ν respective to the fixed intrinsic viscosities chosen from 
literature were: κ/ν = 0.31, using [η]Monkos; and κ/ν = 0.42, 
using [η]Tanford. These values were comparable to values 
reported for other globular proteins, such as IgG (κ/ν = 0.37 to 
0.49) and hemoglobin (κ/ν = 0.40).12,18,35  
 The Ross Minton model was fitted to the data allowing free 
parameters. The best fit computed was using experimental 
data up to ~350 mg/mL (Fig. 6 – green line). Both the [η] 
(4.21×10-3  mL/mg) and κ/ν (0.45) values were in agreement to 
the values reported in literature.8,15,20 This fitted intrinsic 
viscosity value was similar to the intrinsic viscosity value 
calculated with triple detection HPSEC for the monomer peak 
of rAlbumin (Table 1). However, the Ross-Minton model did 
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not predict solution viscosity for the highest concentrations (≥ 
350 mg/mL). 
 The rheology data was fitted to the other hard-sphere 
model, the Krieger-Dougherty equation (eq. 3). First, the 
intrinsic viscosity ([η]) was fixed to 2.5, defined for spheres, 
and setting the maximum packing fraction (!max) to 0.64. 
Then, the data was fitted defining the maximum packing 
fraction to 0.71, while still assuming the protein species were 
spherical ([η] = 2.5). In both cases, fixing intrinsic viscosity to 
2.5 and φmax could only predict the data up to 100 mg/mL, 
which is in agreement with the literature7 (Fig. 7A – orange 
and magenta lines). 
 Conversion of weight/volume concentration to volume 
fraction was calculated via the polymer chemistry equation for 
volume fraction (!  IJKL MNO⁄ ), taking into account the 
hydrated molecular weight of the protein - MWh (eq. 10). The 
hydrated protein molecular weight was calculated from MWh = 
MWp(1 + δ), where MWp is the molecular weight of the protein 
and δ is the amount of water associated with the 
macromolecule in g/g.8,15 
!  	QRS IJK +	QRTUV  (10) 
where c is the concentration in mg/mL, NA is Avogadro's 
number, V is the protein's hydrodynamic volume (113.4 nm3),  
and ρ is the density of water at 20 °C (998.2×103 mg/mL) and δ 
= 0.379.8 
 The data was fitted to this model with free parameters, 
allowing a prediction of viscosity applied to non-spherical 
particles (Fig. 7A – blue line). The parameters which were best 
fits using data up to 350 mg/mL, were [η] = 6.94 ± 0.14 and !max = 0.298 ± 0.002 (with r2 = 0.9996 and χ2 = 0.26). In this 
case, the fitted intrinsic viscosity showed a higher value than 
that corresponding to spheres, indicating that particle aspect 
ratio had increased and the !max decreased respectively. These 
values suggest good physical significance, since their product is 
still within their usual range 1.4 < [η]/!max < 4.43 The fitted 
intrinsic viscosity value of ~6.9  agreed with the reported 
aspect ratio of albumin, known to be a prolate ellipsoid.8,15,40 
Altogether, these observations along with those previously 
made from the Ross-Minton model, point to a difficulty in 
prediction of solution viscosity of concentrations > 350 mg/mL 
(see Fig. 6 (green line) and 7A (blue line)).   
 The Russel-Saville-Schowalter equation4 (eq. 4), was used 
to fit our data since it takes into account the interparticle 
interaction. To fit the data to this model, s, the term which is 
defined by the effective distance between particles, was 
initially chosen to be equal to 6.2, as per Batchelor’s proposal 
applied to repulsive hard spheres.4 However, Sharma et al.7 
showed that the data of concentrated BSA solutions up to 250 
mg/mL could fit with this model (with data up to ~250 mg/mL) 
using a value s = 10. The authors suggested that this value 
would correspond to an interaction potential corresponding to 
a deff = 2.5a, reflecting BSA's repulsive net negative charge in a 
saline buffer at pH ~7 10. The comparability between rAlbumin 
(or HSA) and BSA can be made since these two albumin 
variants share >75% of their primary structure and many 
physical properties (e.g. surface hydrophobicity), having 
however, slight differences with regards to its thermal 
stability, electrophoretic behaviour and binding properties. 
44,45 
 This model could not predict the viscosity of our 
experimental data at concentrations higher than ~150 mg/mL 
(! = 0.11), even when fixing s = 10 (Fig. 7B). Since this model 
fixes the intrinsic viscosity at 2.5 for hard spheres, while it has 
been previously discussed that rAlbumin (and BSA) are not 
spherical but prolate ellipsoids, it may well not be the most 
appropriate albeit the only equation that includes surface 
charge as determinant to the viscosity of globular protein 
solutions.  
 The rheology data was further analysed using the 
generalised equations of Minton and Krieger-Dougherty for 
protein viscosity (eq. 7 and 8, respectively), which account for 
the presence of multiple species of protein in solution. By 
fitting these two generalised models to the experimental 
rheology data, it was found that the best fits would be 
achieved if the concentration range would not include either 
the last three (for eq. 8) or two data points (for eq. 7) (Fig. 8). 
The fitted weight-averaged intrinsic viscosity and w* values 
suggest conformity between both generalised models. By 
using these generalised models it is still not possible to predict 
the higher concentrations above ~350 mg/mL. When fitting 
the experimental data using all the data points available, the 
fitted parameters usually presented poor statistical 
correlations (r2 < 0.9, χ2>> 1) as well as higher values for [η]w 
with no physical significance. 
 In the study by Galush et al.26, the protein mixtures were 
always prepared to a known total weight/volume 
concentration and known weight fractions of each of the 
proteins in the mixture. In our case, the presented HPSEC 
results (Fig. 2B) showed that the monomer, dimer and trimer 
composition was changing with sample concentration. 
Therefore, a weight-averaged intrinsic viscosity was calculated 
per sample (eq. 9), instead of being assumed to remain 
constant (Table 2), using the data obtained by triple detection 
HPSEC (Table 1). The weight-averaged intrinsic viscosity values 
were slightly affected. 
 Using the calculated weight-averaged intrinsic viscosity, 
and assuming the different w* values based on the fitted 
parameters obtained above, the viscosities were computed for 
the studied concentrations (Fig. 9A and 9B) for both 
generalised models. When choosing w* of higher values 
(derived from fits using all data points), the viscosities were 
typically underestimated. On the other hand, using w* values 
that were derived from the best fits, 569 mg/mL for the 
generalised Ross-Minton model (eq. 7), or 399 mg/mL for the 
generalised Krieger-Dougherty model (eq. 8), the viscosities 
were correctly predicted for the higher concentrations up to, 
and including, 450 mg/mL and 350 mg/mL, respectively. 
Discussion 
The biophysical characterisation reported here aimed at 
providing a clear characterisation of the rheological behaviour, 
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and the protein species content, of dilute to highly 
concentrated solutions of rAlbumin. From the steady shear 
rheology of these solutions, it was concluded that they showed 
a Newtonian-like behaviour. This is in clear contrast to 
previous studies of the rheology of globular proteins7,33,34,46 
where an apparent yield-behaviour has been reported, 
particularly at lower shear rates (< 10 s-1). The reason for this 
purely viscous Newtonian-like behaviour is likely due to the 
presence of polysorbate-80, a well-known surfactant used in 
biopharmaceutical formulations. This is proposed to negate 
the effect on rheological properties of surface tension that can 
occur due to formation of a protein film at the air-water 
interface.7 Similar rheological behaviour has been reported for 
globular protein solutions in a buffer also containing a 
polysorbate surfactant.47,48 
 Fig. 2A clearly shows the viscosity increase with protein 
concentration. From the data in the figure, it is clear that a 
larger increase in viscosity occurred between concentrations 
~250 and ~500 mg/mL. The ~500 mg/mL sample reached a 
high shear rate viscosity of ~10 000 times larger than that of 
water (1.0016 mPa.s at 20 ºC, as defined by NIST). Although 
biopharmaceutical formulations are not typically formulated at 
more than 200 mg/mL, the literature has discussed similar 
increases of viscosity.14,26,35 Therefore, analysing the viscosity 
increase with concentration of rAlbumin solutions as a 
biopharmaceutical formulation model will help understand 
what factors govern this exponential rise in viscosity. 
 To correlate this increase in viscosity with the increase in 
protein concentration and its level of aggregation, further 
characterisation with HPSEC was needed. From Fig. 2B it is 
clear that there is an increase in dimer and trimer content for 
samples > 250 mg/mL. 
 Triple-detection HPSEC allowed determination of the 
intrinsic viscosity and MW of each protein species detected in 
the conditions used here. Experimentally calculated molecular 
weight values for monomers and dimers agreed well with the 
values reported in literature for human serum and bovine 
serum albumin.36 The values for intrinsic viscosity detected 
were however, quantitatively different to those in the 
literature, possibly due to differences in experimental 
conditions (e.g. temperature, mobile phase buffer and flow 
rate), which can affect the working conditions of the 
differential viscometer. However, our results for intrinsic 
viscosities were still statistically different (p<0.05, one-way 
ANOVA) between monomer and dimer at every concentration 
studied. No variation with concentration was observed for the 
intrinsic viscosity values within specific molecular weight 
ranges. 
 The results obtained by DLS were similar to those 
described in literature40 – only one peak was detected, with 
radii between 3.8 – 4.5 nm corresponding to the 
hydrodynamic radius of monomeric recombinant human 
albumin (Fig. 3). The hydrodynamic size distribution by volume 
showed a slight skew towards monomer size. This reflects the 
higher relative contribution of monomer in comparison to low 
relative quantity of dimers and trimers in solution. Data from 
microfluidic SDS-PAGE (Fig. SI-3) confirmed the presence of 
monomers and dimers in the diluted solutions of samples from 
200 – 500 mg/mL, and that no other higher molecular weight 
aggregates were present. This information was in agreement 
with our data from HPSEC characterisation. 
 Finally, the rheology results reported in Fig. 4 and Fig. 5 
(recorded with mVROC) show that the rheology data of 
rAlbumin solutions recorded with a cone and plate rheometer, 
were free from surface-tension effects. When, samples were 
diluted with surfactant-free buffer it was clear that there were 
differences in the measured viscosities at high shear, 
compared to formulated protein solution. These differences 
are proposed be related to the lower concentration of 
polysorbate-80 present in the 5 and 10 mg/mL samples, and to 
some extent those at 50 mg/mL. Polysorbate-80 is present in 
the formulation to prevent the macromolecule reaching the 
air/water and solid/water interface.27 In these samples, as the 
surfactant was diluted during sample preparation to below its 
effective concentration, it likely ceased to be sufficient in 
preventing the protein from reaching the air-water interface 
present when using the cone-plate geometry. As mentioned 
before, such surface tension effects have been proposed to 
influence torque measurements at low shear rates, leading to 
an apparent yield-behaviour observed as a pronounced 
increase in the slope of the viscosity function7, where the 
sample is no longer Newtonian. Other authors also observed 
similar differences when adding surfactants to globular protein 
solutions.47,48 By studying the rheology of protein samples 
prepared in surfactant-containing buffer, it is proposed that 
the values of viscosity and shear stress measured and are 
similar to a measurement performed with an air-water 
interface-free instrumentation, such as the mVROC.   
 The results discussed so far showed that the rAlbumin 
solutions studied were constituted mainly of monomeric 
species with a small percentage of dimers and trimers, which 
increases, at the expense of monomers present in solution, 
when the solution is concentrated > 250 mg/mL. Since this was 
also the concentration at which an increase in solution 
viscosity was noticed, it was important to analyse our rheology 
data with models that should predict the increase of viscosity 
with concentration.  
 In summary, our analysis suggested that concentrations 
above ~350 mg/mL have a solution viscosity that depends on 
factors other than those taken into account by the models 
explored here. These models have been developed based on 
their application to low concentrations of particle suspensions, 
where each particle would be far apart from another enough 
to not influence its flow.15 Therefore, it is not surprising that 
these equations always apply well to lower concentrations of 
albumin. 
 Although the models presented here are based on hard 
quasi-spherical repulsive particles and their excluded volume, 
the predicted data typically suggest that a maximum packing 
fraction of rAlbumin (based on the best fits) will always be 
lower than the highest concentrations achieved 
experimentally (~450 - 500 mg/mL). In addition, viscosity 
prediction, according to pure hard-sphere particle models, 
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clearly underestimates the viscosity values for concentrations 
higher than ~100 - 150 mg/mL.  
 One possible suggestion to explain such deviation from 
predictions at high concentration is that the maximum packing 
concentration could be dependent on solution composition 
e.g. the relative quantity of monomers and oligomeric species 
such as dimers and trimers. It is known that suspensions 
composed of binary sized spherical particles yield a maximum 
packing fraction approximately larger than the random close 
packing for a homogenous suspension.5,23–25 However, albumin 
is a prolate ellipsoid that has been shown to influence the 
maximum packing fraction. It has been predicted that for 
globular protein solutions up to approximately 250 mg/mL 
with the protein having a 5:1 aspect ratio, the increase of 
jamming limit would not be significant.14 The models 
employed so far assume that associative species remain with 
the same globular shape, which is clearly not the case. 
 Apart from shape, it is unlikely that rAlbumin could 
resemble a hard particle, as its homologue HSA has been 
reported to exhibit a drop in intrinsic viscosity with 
temperature increase8, and its mammalian variant BSA has 
been shown to have an intrinsic viscosity which is pH-
dependent.49 These studies, along with others from protein 
hydrodynamic analysis 44,50, point towards the influence of 
protein conformation in viscosity studies, via a change in 
intrinsic viscosity depending on the solution conditions. 
Therefore, as the protein is further concentrated, changes in 
protein conformation could be a factor to account for the slow 
increase of viscosity compared to hard sphere model 
predictions. In addition, this slow increase could also be due to 
the repulsive nature of inter-protein interactions, which is a 
phenomenon that has been observed for sterically stabilised 
colloids.22  
 The deviation from models seen at higher concentrations 
(≥ 350 mg/mL) could be related to a glass transition similar to 
that which occurs with colloidal hard spheres. In this case, 
accounting for repulsive excluded volume, suspensions are 
expected to approach a glass transition at volume fractions ! 
≈ 0.58 before approaching the random close packing fraction 
(! = 0.64).22 When the concentration approaches a glassy 
state, the particle is caged by the presence of neighbouring 
particles, thus slowing down its flow and leading to increased 
viscosities. In the case of rAlbumin, an analogous glass 
transition behaviour could be taking place at the 
concentrations between ~400 to ~500 mg/mL based on similar 
results seen with highly concentrated solutions of BSA.51 This 
would suggest that these concentrations are approaching the 
jamming limit but does not explain why viscosities cannot be 
predicted in conventional models. Finally, it is precisely the 
sample range between 350 mg/mL and 500 mg/mL that 
showed an increase in the relative quantity of dimers (with a 
respective decrease of monomers). Therefore, it does suggest 
that the change of composition and the increase of viscosity 
with increase of concentration are connected and needs to be 
addressed in these models. 
Conclusions 
In this work a range of rAlbumin solutions, in a formulation 
buffer containing NaCl and a surfactant, were analysed for 
their rheological behaviour with the aim of understanding the 
effects of high concentration on solution viscosity. Rheological 
measurements showed that the solutions behaved as purely 
viscous fluids in the range of the applied shear rates. It was 
observed that as the protein concentration increased in 
solution, the samples presented an increase of viscosity. All 
samples showed the same oligomeric species were present in 
solution; monomers, dimers and trimers of rAlbumin. As 
concentration increased to ~500 mg/mL, the relative quantity 
of dimers and trimers increased along with a corresponding 
decrease of monomer. By DLS and microfluidic SDS-PAGE 
analysis, the solutions showed no other signs of impurities 
such as other higher order aggregates or protein fragments. 
Throughout this study several experiments proved that 
concentrating the rAlbumin ≥ 200 mg/mL did not seem to have 
any other effect besides the increase of solution viscosity and 
the change in relative composition of protein species. 
 A comprehensive theoretical analysis of the rheological 
experimental data was performed using different models that 
are commonly applied to predict protein solution viscosity. The 
Ross-Minton and Krieger-Dougherty equations were 
demonstrated to predict our experimental data up to 350 
mg/mL. When considering the protein inter-distance and thus 
the effect of interaction potential upon viscosity, the solution 
viscosity couldn't be predicted for concentrations ≥ 150 
mg/mL. 
 Generalised versions of the Ross-Minton and Krieger-
Dougherty equations were also studied and the results showed 
that the former could successfully fit when using experimental 
data up to ~400 mg/mL of rAlbumin. Although these models 
assume that the protein species are hard particles throughout 
all conditions observed, the equations account for 
multiple/oligomer species, which determines a weighted 
approach to intrinsic viscosity suggesting a variation in these 
species as protein concentration increases. The fact that our 
analysis produced better fits using these generalised equations 
further highlights the importance of considering the variation 
in composition within a protein solution, thus justifying the 
complete characterisation of oligomeric species present. It is 
important to note that no other analysis typically accounts for 
this variation using a sample composed of one protein only. 
We however suggest that other factors related to highly 
concentrated solutions may still also need to be considered, 
particularly since those concentrations not fitted were the 
most concentrated (> 400 mg/mL), where crowding effects 
should be more accentuated.  
 In conclusion, the example of rAlbumin explored here 
highlights that knowledge of how the protein oligomeric 
species composition varies between samples of increasing 
concentration, is a key factor for predicting the viscosity of 
protein solutions. Application of this knowledge to liquid 
formulations of therapeutic macromolecules (such as mAbs) 
would be important to further understand further its solution 
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viscosity. However, in this case, protein structure could also 
play an important role, where protein-protein interactions 
between protein domains have been shown to also influence 
solution viscosity.11,12  
 The relevance of this study to pharmaceutical sciences is 
that it ultimately shows the importance of better 
understanding the underlying factors leading to the high 
viscosity of highly concentrated biopharmaceutical liquid 
formulations. By using improved models, prediction of protein 
solution viscosity could eventually bring advantage to early 
phase development studies, and ultimately help develop 
better highly concentrated biopharmaceutical formulations, 
allowing painless sub-cutaneous administration to patients. 
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Figures/ Tables 
Fig. 1 Experimental steady shear rheology of rAlbumin solutions obtained with cone-plate 50 mm, 1°, or cone-plate 40 mm, 0.3°, at 20 °C. 1A and 1B - Viscosity values are 
shown for ramping down (closed circles) and ramping up (lines) shear rates. A - Samples from 0.1 to 100 mg/mL. B - Samples from 10 to 500 mg/mL. C - Flow curves for 
experimental steady shear rheology of rAlbumin solutions from 10 to 500 mg/mL. Shear stress values are shown only for ramping down shear rates. 
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Fig. 2 A Viscosity of rAlbumin solutions ranging from 0.1 mg/mL to 500 mg/mL (target concentrations). Viscosities are taken at high shear (η = 1000 s-1) at 20 °C. Viscosity values 
are represented as an average and standard deviation (error bars) of 3 separate measurements for each sample. Concentrations are represented as average of 3 measurements 
and error bars are standard deviation. B HPSEC conventional method for determining level of aggregation of rAlbumin solutions showing relative peak areas in %. Data in squares 
represent an average of 3 readings per sample. Error bars are standard deviation per sample for peak area % (y-axis) and for concentration (x-axis). All samples were diluted to 10 
mg/mL prior to analysis when necessary. 
 
Table 1 HPSEC triple detection values of peak area, bulk molecular weight (MW) and bulk intrinsic viscosity (IV) for monomers and dimers detected in rAlbumin solutions. Average 
and standard deviations are reported for 3 separate measurements per sample. 
 
Sample 
(mg/mL) 
Monomer Dimer  
Peak Area (%) MW (kDa) [η] (mL/mg) Peak Area (%) MW (kDa) [η]  (mL/mg) 
50 96.11 ± 0.03 64988 ± 297 0.00408 ± 0.00004 3.89 ± 0.02 121239 ±1171 0.00482 ± 0.00014 
100 95.97 ± 0.10 65449 ± 933 0.00402 ± 0.00017 4.03 ± 0.10 143044 ± 12519 0.00446 ± 0.00089 
200 95.71 ± 0.01 64656 ± 580 0.00408 ± 0.00006 4.29 ± 0.01 130356 ± 1563 0.00477 ± 0.00044 
250 95.68 ± 0.01 64791 ± 749 0.00409 ± 0.00006 4.32 ± 0.01 132466 ± 5446 0.00505 ± 0.00072 
350 94.69 ± 0.24 66090 ± 1780 0.00412 ± 0.00005 5.31 ± 0.24 138341 ± 8136 0.00441 ± 0.00101 
400 94.46 ± 0.02 65290 ± 185 0.00410 ± 0.00003 5.54 ± 0.02 132674 ± 3686 0.00489 ± 0.00050 
450 94.33 ± 0.01 65358 ± 184 0.00408 ± 0.00004 5.67 ± 0.01 131680 ± 3886 0.00462 ± 0.00047 
500 93.90 ± 0.01 65066 ± 242 0.00412 ± 0.00006 6.10 ± 0.01 132140 ± 4754 0.00467 ± 0.00056 
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Fig. 3 Dynamic light scattering plots for 200 mg/mL rAlbumin solution diluted to 1 mg/mL. Size distributions by intensity (black line), and by volume (red line). 
 
 
Fig. 4 mVROC data for 200 mg/mL of rAlbumin in comparison to the cone-and-plate rheology data of the same sample. mVROC data: crosses - ramping up shear rates, dashed lines 
- ramping down shear rates; CP rheology data: closed circles - ramping up shear rates; lines – ramping down shear rates. 
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Fig. 5 Viscosity curves for rAlbumin solutions diluted in 145 mM NaCl buffer, in comparison to the material in formulation buffer, at the same concentrations: 5, 10, 50 and 100 
mg/mL. Half circles – rAlbumin in 145 mM NaCl only; full circles - rAlbumin in formulation buffer. Inset focuses on the viscosities of these samples at the higher shear rates. 
 
Fig. 6 Experimental cone-and-plate rheometry data (squares) fitted to Ross-Minton's equation (eq. 2). Relative viscosity was obtained by dividing each of the samples high shear 
viscosity (~1000s
-1
) by the averaged buffer viscosity 1.038 ± 0.013 mPa.s. Fits were calculated by fixing [η] and leaving the parameter κ/ν free and are as follows: blue line, [η] = 
4.72×10
-3
  mL/mg (from [3]), κ/ν = 0.31 ± 6.6×10-4, r2 = 0.95; orange line, [η] = 0.0037 mL/mg (from [31]), κ/ν = 0.42 ± 6.9×10-4, r2 = 0.94. Green line represents best fit of the same 
equation to experimental data using free parameters. Fit was calculated leaving both [η] and κ/ν free: [η] = 4.21×10
-3
  ± 1.5×10
-4
; κ/ν = 0.45 ± 0.024; r
2
 = 0.999 and χ
2
 = 0.40. 
Experimental data used for this fit was only up to 350 mg/mL. 
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Fig. 7 A Experimental cone-and-plate rheometry data (squares) plotted against expected data (lines) from Krieger-Dougherty's equation (eq. 3) with fixed parameters. Relative 
viscosity was calculated by dividing each sample's (η (1000 s-1)) by the buffer's viscosity (η0= 1.038 ± 0.013 mPa.s). For both lines, [η] was fixed to 2.5, but different ϕmax were used: 
0.64 (orange); 0.71 (magenta). See text for more details. Data was fittted to Krieger- Dougherty's equation using free parameters (blue). Computed parameters were [η] = 6.9 ± 
0.14, ϕmax = 0.30 ± 0.0025, with r
2 = 0.999 and χ2 = 0.26. Experimental data used for was up to 350 mg/mL. B Experimental cone-and-plate rheometry data (squares) plotted against 
expected data (lines) from Russel's equation (eq. 4) using fixed parameters. For both lines, [η] was fixed to 2.5, but s was: 6.2 (red line); 10 (green line). 
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Fig. 8 Experimental data fitted to the generalised Krieger-Dougherty equation (eq. 8; blue line). Fitting parameters were [η]w = 0.00517 ± 1.1×10-4 mL/mg, w* = 399 ± 3.4 mg/mL, 
with r2 = 0.999 and χ2 = 0.26. Data used was up to 350 mg/mL. Experimental data fitted to the generalised Ross-Minton equation (eq. 7, red line). Fitting parameters were [η]w = 
0.00479 ± 4.0×10-5 mL/mg, w* = 569 ± 2.2 mg/mL, with r2 = 1.0 and χ2 = 0.91. Data used was up to 400 mg/mL. For both plots, relative viscosity was calculated by dividing the 
sample's η(1000s-1) by the buffer's viscosity (1.038± 0.013 mPa.s). 
 
 
Table 2 Table with calculated [η]w for rAlbumin solutions based on the experimental HPSEC triple detection data. [η]1 and [η]2 correspond to the average experimental intrinsic 
viscosity for monomer and dimer, respectively. f1 and f2 correspond to the fraction of relative peak area for monomer and dimer, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sample 
Concentration 
(mg/mL) 
Monomer Dimer 
[η]w 
f1 , peak area 
fraction 
w1 , mass 
fraction 
[η]1*w1 
([η]1=0.00409 
mL/mg) 
f1 , peak area 
fraction 
w1 , mass 
fraction 
[η]1*w1 
([η]1=0.00471 
mL/mg) 
50.2 0.961 48.24 0.197 0.039 1.96 0.009 0.00411 
96.0 0.960 92.16 0.377 0.040 3.84 0.018 0.00411 
190.8 0.957 182.60 0.747 0.043 8.20 0.039 0.00412 
253.1 0.957 242.22 0.991 0.043 10.88 0.051 0.00412 
354.2 0.947 335.43 1.372 0.053 18.77 0.088 0.00412 
398.0 0.945 376.11 1.538 0.055 21.89 0.103 0.00412 
440.2 0.943 415.11 1.698 0.057 25.09 0.118 0.00413 
506.8 0.939 475.89 1.946 0.061 30.91 0.146 0.00413 
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Fig. 9 A Experimental data (squares) plotted against the calculated viscosities (lines) based on the generalised Ross Minton equation (eq. 7). Data was calculated when fixing the 
w* to 530 mg/mL (blue), 816 mg/mL (red) and 568 mg/mL (green). Fitted w* values used were from best fits to eq. 7. B Experimental data (squares) plotted against the calculated 
viscosities (lines) based on the generalised Krieger-Dougherty equation (eq. 8). Data calculated when fixing the w* to 1298 mg/mL (black), 399 mg/mL (blue), 576 mg/mL (orange), 
and 445 mg/mL (light green). Fitted w* values used are from best fits to eq. 8. For both plots, expected viscosities were calculating using [η]w calculated in Table 2.  
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rAlbumin solutions of increasing concentrations show heterogeneity in 
protein species and its content, which has effect on protein solution viscosity.
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